Aging-US

mTORC1 in Classical Monocytes: Links to Human Size Variation & Neuropsychiatric Disease


Listen Later

BUFFALO, NY- August 7, 2024 – A new #research paper was #published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 14 on July 26, 2024, entitled, “mTORC1 activation in presumed classical monocytes: observed correlation with human size variation and neuropsychiatric disease.”
In this new study, researchers Karl Berner, Naci Oz, Alaattin Kaya, Animesh Acharjee, and Jon Berner from Woodinville Psychiatric Associates, Virginia Commonwealth University, University of Birmingham, University Hospitals Birmingham, and MRC Health Data Research UK, aimed to measure phosphorylated p70S6K, a marker for mTORC1 activity, in individuals with psychiatric disease to determine whether phosphorylated p70S6K could predict medication response.
Their results showed that mTORC1 activity correlated highly with classical biometrics (height, macrocephaly, pupil distance) and specific neuropsychiatric disease profiles (anxiety and autism).
“Our data suggest that human variability of mTORC1 gain of function observed during the differentiation of stem-like monocytes into vascular tissue-resident macrophages correlates with physical size, subsets of neuropsychiatric disease, and clinical ketamine or rapamycin response.”
DOI - https://doi.org/10.18632/aging.206033
Corresponding author - Jon Berner - [email protected]
Video short - https://www.youtube.com/watch?v=EXzX6CjtAHc
Sign up for free Altmetric alerts about this article -
https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206033
Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts
Keywords - aging, ketamine, lithium, monocyte, mTORC1, rapamycin
About Aging-US
The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.
The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)
Please visit our website at https://www.Aging-US.com​​ and connect with us:
Facebook - https://www.facebook.com/AgingUS/
X - https://twitter.com/AgingJrnl
Instagram - https://www.instagram.com/agingjrnl/
YouTube - https://www.youtube.com/@AgingJournal
LinkedIn - https://www.linkedin.com/company/aging/
Pinterest - https://www.pinterest.com/AgingUS/
Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc
...more
View all episodesView all episodes
Download on the App Store

Aging-USBy Aging-US Podcast

  • 4
  • 4
  • 4
  • 4
  • 4

4

2 ratings


More shows like Aging-US

View all
This American Life by This American Life

This American Life

90,929 Listeners

WTF with Marc Maron Podcast by Marc Maron

WTF with Marc Maron Podcast

29,039 Listeners

Boundless Life by Ben Greenfield

Boundless Life

5,002 Listeners

The Daily by The New York Times

The Daily

112,022 Listeners

Up First from NPR by NPR

Up First from NPR

56,495 Listeners

Today, Explained by Vox

Today, Explained

10,203 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

8,482 Listeners

Wild Health Podcast by Wild Health

Wild Health Podcast

441 Listeners

Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+ by Everyday Wellness™

Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+

136 Listeners

Consider This from NPR by NPR

Consider This from NPR

6,394 Listeners

The Weekly Show with Jon Stewart by Comedy Central

The Weekly Show with Jon Stewart

10,702 Listeners

ZOE Science & Nutrition by ZOE

ZOE Science & Nutrition

2,060 Listeners

The Optispan Podcast with Matt Kaeberlein by Optispan

The Optispan Podcast with Matt Kaeberlein

40 Listeners